Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Guggenheim's"


25 mentions found


Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailExpect restaurants impacted by hurricanes to 'bounce back quickly', says Guggenheim's Greg FrancfortGregory Francfort, Guggenheim Securities lead restaurant analyst, joins CNBC's 'The Exchange' to discuss the economic impact of Hurricane Milton on restaurants, how long it will take those affected to bounce back, and more.
Persons: Greg Francfort Gregory Francfort Organizations: Guggenheim Securities Locations: Hurricane Milton
Falaise is one of three 100-year-old mansions open to tour at Sands Point Preserve on Long Island. Falaise was built by Harry Guggenheim in 1923 and was modeled on a 13th-century French manor. Inside Sands Point, there are four mansions. In September, I visited Sands Point to see Falaise, the most mysterious of the three — tours are only available on weekends and you can only get there via Sands Point's transportation. Here's what it was like to visit Harry Guggenheim's summer home.
Persons: Harry Guggenheim, Guggenheim, , Scott Fitzgerald's, Nick, Gatsby, Jordan, Daisy, Gould, Harry Guggenheim's Organizations: Service, Guggenheim, Hempstead House Locations: Falaise, Sands, Long, Nassau County, Shore, West Egg, Sands Point, Hempstead, Mille Fleurs
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via Email'Good news actually means good news' in this market, says Guggenheim's Eric MandlEric Mandl, Guggenheim senior managing director, joins 'Closing Bell Overtime' to talk what the Fed rate cuts mean for M&A activity.
Persons: Eric Mandl Eric Mandl Organizations: Guggenheim
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailHard to justify Tesla's valuation without robotaxis, says Guggenheim's Ronald JewsikowRonald Jewsikow, Guggenheim Analyst, joins 'Closing Bell Overtime' to talk Tesla's down day following robotaxi delay.
Persons: Ronald Jewsikow Ronald Jewsikow Organizations: Guggenheim
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailRobotaxis are as much of a risk for Tesla as an opportunity, says Guggenheim's Ronald JewsikowRonald Jewsikow, Guggenheim analyst, joins 'Closing Bell Overtime' to talk his bear case for Tesla.
Persons: Tesla, Ronald Jewsikow Ronald Jewsikow Organizations: Guggenheim
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailElection outcomes in this cycle are more significant than past: Guggenheim's Eric RutkoskeEric Rutkoske, Guggenheim global head of M&A, joins 'Money Movers' to discuss what's driving the jump in M&A in Europe, the mixed signals Rutkoske is seeing, and more.
Persons: Eric Rutkoske Eric Rutkoske Organizations: Guggenheim Locations: Europe
Waste Management , Stericycle — Waste Management is buying Stericycle for $7.2 billion , the companies announced on Monday. Stericycle shares jumped nearly 15%, while Waste Management slid 4%. Spotify — The music streaming company climbed 4% following its announcement of premium subscription price increases in the U.S. in July. Lattice Semiconductor , Coherent — Lattice shares dove 11% after CEO Jim Anderson left to take the helm at Coherent, whose stock price jumped 17%. Krispy Kreme — Shares of the company rose 2% after it was upgraded to overweight at JPMorgan.
Persons: Keith Gill, Gill, Stericycle, CNBC's David Faber, Skydance, Shari Redstone, Jim Anderson, Esam, Dickinson, Edwards, Narendra Modi, Claudia Sheinbaum, Cava, Blackwell, Krispy Kreme, Masimo, Piper, Piper Sandler, Goldman Sachs, Goldman, — CNBC's Sean Colon, Yun Li, Pia Singh, Michelle Fox, Christina Cheddar, Berk Organizations: GameStop, DeepF, AMC, New York Stock Exchange, Waste Management, Spotify, GSK, Court, Paramount Global, Lattice Semiconductor, Company, Bloomberg News, JPMorgan, Nvidia, AMD, Bank of America, Therapeutics, Autodesk Locations: U.S, Swedish, Delaware, Becton, India, Mexico
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailMacy's is off to an encouraging start with new leadership, says Guggenheim's Bob DrbulBob Drbul, Guggenheim Securities equity research analyst, joins 'Squawk Box' to discuss Macy's quarterly earnings results, how the company's restructuring efforts are going, and more.
Persons: Bob Drbul Bob Drbul Organizations: Guggenheim Securities
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailFiscal spending offset much of the Fed's quantitative tightening, says Guggenheim's Anne WalshHosted by Brian Sullivan, “Last Call” is a fast-paced, entertaining business show that explores the intersection of money, culture and policy. Tune in Monday through Friday at 7 p.m. ET on CNBC.
Persons: Guggenheim's Anne Walsh, Brian Sullivan, Organizations: CNBC
Disney is an outstanding asset, says Guggenheim's Michael Morris
  + stars: | 2024-05-07 | by ( ) www.cnbc.com   time to read: 1 min
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailDisney is an outstanding asset, says Guggenheim's Michael MorrisMichael Morris, Guggenheim Securities entertainment & media analyst, joins 'Squawk on the Street' to discuss Disney as shares fall on its Q2 earnings results.
Persons: Guggenheim's Michael Morris Michael Morris Organizations: Guggenheim Securities, Disney
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailCompanies willing to disrupt themselves will be the winners in the market, says Guggenheim's Eric MandlEric Mandl, Guggenheim Securities Sr. Managing Director, joins 'Closing Bell: Overtime' to discuss IPOs and dealmaking and outlook for the sector.
Persons: Eric Mandl Eric Mandl Organizations: Email Companies, Guggenheim Securities
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailInvestments that are good for both the climate & economy completely overlap: Guggenheim's SchwartzCNBC's Brian Sullivan interviews Alan Schwartz, Guggenheim Partners, from the CERAWeek conference in Houston, Texas.
Persons: Guggenheim's Schwartz, Brian Sullivan, Alan Schwartz Organizations: Investments, Guggenheim Partners Locations: Houston , Texas
The health-care sector of the S & P 500 is up about 8% year to date, marking a sharp comeback from a largely flat 2023. Even as health care is making a comeback this year, investors shouldn't forget its defensive attributes. Back in 2022, when the S & P 500 fell 19.4%, the health-care sector slipped only 3.5% "When markets are challenged, health care can be a good place to be," Lyons added. Some of them speak to the growth aspects of health care and why you can play offense." Merger activity is another driver of growth in health care, as large pharmaceutical companies snap up nimble biotech firms that are at the forefront of developing treatments.
Persons: Dan Lyons, Janus Henderson, shouldn't, Lyons, ImmunoGen, Seamus Fernandez, Sotatercept, Cigna, Cantor Fitzgerald, Sarah James, Fred Imbert Organizations: Big Tech, . Healthcare, Janus, Janus Henderson Investors, U.S . Food, Drug Administration's Center, Drug, Research, FDA, Esai, Pharmaceuticals, CNBC Pro, Merck, Abbott Laboratories, AbbVie, CVS Health Locations: U.S
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailInvestors are surprised by Warner Bros. Discovery's lack of full-year guidance: Guggenheim's MorrisMichael Morris, Guggenheim Securities entertainment and media analyst, joins 'Squawk on the Street' to discuss what Morris makes of Warner Bros. Discovery's quarterly earnings results, why the company decided not to release full-year guidance, and more.
Persons: Guggenheim's Morris Michael Morris, Morris Organizations: Investors, Warner Bros, Guggenheim Securities
Fox, who has Parkinson's disease, told the audience that movies "can change your life." Fox received a standing ovation at the 2024 BAFTAs on Sunday night in a rare awards show appearance. Aside from being one of the biggest stars of the 1980s, in 2000, the actor started The Michael J. Fox Foundation to fund research into a cure for Parkinson’s disease, and has since raised over $2 billion for research. Although Fox retired from acting in 2022, he was recently the focus of Davis Guggenheim's 2023 documentary, "Still: A Michael J.
Persons: Michael J, Fox, Oppenheimer, , David Tennant, Christopher Nolan's, Marty McFly, Davis, Organizations: Service, Fox, Fox Foundation, Guardian Locations: London
Tesla is set to kick off deliveries of its long-awaited Cybertruck Thursday, but not everyone on Wall Street is convinced the debut will move the needle in terms of stimulating growth for the Elon Musk-run company. TSLA 1M mountain Tesla shares over the last month To be sure, despite some cautionary commentary from major Wall Street firms, Tesla shares have almost doubled in 2023 as investors veered back into growth stocks. "However unlikely just a few days before first deliveries, canceling Cybertruck would probably be positive for shares," he wrote in a report to clients while reducing his Tesla price target to $210 from $250 a share. By itself, however, the new truck won't help Tesla's shares, Guggenheim believes. Jewsikow most recently retained a $125 price target on the stock, implying 49% downside from Wednesday's close.
Persons: Tesla, Ronald Jewsikow, Philippe Houchois, Tom Narayan, Narayan, Guggenheim's, Tesla's, Guggenheim, — CNBC's Michael Bloom Organizations: Elon, Guggenheim Securities, Tesla, Treasury, Jefferies, RBC Capital, RBC
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailDeflation is right around the corner, says Guggenheim's Bob DrbulBob Drbul, Guggenheim Securities retail analyst, joins 'Power Lunch' to give his read on the big box retailer and the consumer.
Persons: Bob Drbul Bob Drbul Organizations: Guggenheim Securities
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailBob Iger has been 'fixing' Disney and putting the company in a position to grow: Guggenheim's MorrisMichael Morris, Guggenheim Securities media and entertainment analyst, joins 'Squawk on the Street' to discuss why Morris would give Iger a B grade in his first year back as Disney CEO, Morris' expectations for fixing the general entertainment business, and how the analyst would judge Disney's position relative to peers.
Persons: Bob Iger, Guggenheim's Morris Michael Morris, Morris Organizations: Disney, Guggenheim Securities
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailEli Lilly's Zepbound has a strong shot of being the biggest drug of all time: Guggenheim's FernandezGuggenheim analyst Seamus Fernandez joins 'Power Lunch' to discuss Eli Lilly's latest drug to get FDA approval, whether it'll become the biggest-selling drug of all time, and who will be on the hook in paying for Eli Lilly's new drug.
Persons: Eli Lilly's Zepbound, Guggenheim's Fernandez Guggenheim, Seamus Fernandez, Eli, it'll, Eli Lilly's
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailAI will be a multi-trillion dollar opportunity for the industry at large, says Guggenheim's MorrisMichael Morris, Guggenheim Securities entertainment & media analyst, and CNBC's Julia Boorstin\ join 'Squawk on the Street' to discuss Google's earnings miss on its cloud business, whether the stock deserves to be punished how it has.
Persons: Guggenheim's Morris Michael Morris, CNBC's Julia Boorstin \ Organizations: Guggenheim Securities
CNBC Daily Open: Oil deals ahead of Big Tech earnings
  + stars: | 2023-10-24 | by ( Shreyashi Sanyal | ) www.cnbc.com   time to read: +2 min
In this article GOOGL Follow your favorite stocks CREATE FREE ACCOUNTOmar Marques | Lightrocket | Getty ImagesThis report is from today's CNBC Daily Open, our new, international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, no matter where they are. Unlike more focused software companies, Microsoft "has full geographic coverage across all industry verticals," UBS analyst Karl Keirstead said, and that makes Microsoft less susceptible to downturns in any one sector or region. Most analysts predict the sales of weight loss drugs such as Wegovy and Mounjaro could easily exceed $100 billion. Still, that's conservative compared to Guggenheim's expectations of $150 billion to $200 billion in sales.
Persons: Omar Marques, Hess, Canaccord, Tony Dwyer, Karl Keirstead, Mounjaro, drugmaker Eli Lilly Organizations: Lightrocket, CNBC, Big Tech, Nasdaq, Chevron, Exxon Mobil, Stocks, Microsoft, UBS, Wall Street, Citi, Novo Nordisk Locations: .
Most analysts predict the market for new weight loss drugs like Wegovy and Mounjaro will be enormous, but estimates vary for its exact size depending on who you ask. On Monday, Citi raised its estimate for incretin drug sales to $71 billion by 2035, up from its prior estimate of $55 billion. Last month, the firm made a case for there being a $150 billion to $200 billion opportunity for these drugs. At the moment, private insurance coverage isn't a guarantee for those seeking weight loss treatment, and the federal Medicare program doesn't cover weight loss drugs at all. Lilly expects the Food and Drug Administration to approve this drug to treat obesity by the end of this year.
Persons: Seamus, Fernandez, Andrew Baum, Goldman Sachs, Chris Shibutani, Shibutani, Eli Lilly, Lilly Organizations: Monday, Citi, Wegovy, Food and Drug Administration Locations: GLP
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailHere's why Guggenheim's Ron Jewsikow makes the bearish case for TeslaRon Jewsikow, Guggenheim Securities vice president of automotive equity research, joins 'Power Lunch' to make his bearish case for Tesla.
Persons: Ron Jewsikow, Tesla Ron Jewsikow, Tesla Organizations: Guggenheim Securities
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailWe continue to be bullish on the long-term prospects for Netflix, says Guggenheim's Michael MorrisSean McNulty, contributor at The Ankler, and Michael Morris, Guggenheim Securities entertainment and media analyst, join 'Power Lunch' to discuss Netflix as the streaming giant reports its earnings after the bell, whether investors favor the company, and more.
Persons: Guggenheim's Michael Morris Sean McNulty, Michael Morris Organizations: Netflix, Guggenheim Securities
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailWe believe there is a recession coming, says Guggenheim's Alan SchwartzAlan Schwartz, Guggenheim Partners executive chairman, joins 'Squawk Box' to discuss the latest macro outlook, M&A expectations, latest market trends, state of the U.S. economy, and more.
Persons: Guggenheim's Alan Schwartz Alan Schwartz Organizations: Guggenheim Partners Locations: U.S
Total: 25